False
November 9, 2026
As biologics portfolios expand and average product volumes fall, Miriam Monge asks whether today’s major manufacturing investments offer the flexibility tomorrow’s market will require
5 min read
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine
View Profile
Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale
All the latest Medicine Maker articles.
November 4, 2026
Stella Vnook explains why broader representation at the investment table can strengthen biotech, expand support for women-led companies, and accelerate innovation in women’s health
9 min read
November 4, 2026
West Pharmaceutical Services’ Whitney Winters discusses how injection device design can support patient comfort, confidence, and independence
5 min read
November 3, 2026
The company also reported early efficacy and safety data from the Phase I Breakfree-2 study
2 min read
November 3, 2026
China sets out its stall for global biopharmaceutical preeminence as the US faces further uncertainty over research funding and regulation
23 min read
November 3, 2026
Immunopeptidomics is helping researchers identify tumor-presented antigens that could inform the development of targeted cell therapies and personalized cancer vaccines
3 min read
November 2, 2026
Early characterization and manufacturing planning can help developers choose the right formulation strategy for complex oral therapies
5 min read
November 2, 2026
Review examines how PAT, model-based control, reinforcement learning, and digital twins could maintain product quality from perfusion culture through downstream purification
2 min read
November 2, 2026
Phase I data show B-cell depletion and mostly stable or improved disability scores, but the uncontrolled study remains small and follow-up is limited
2 min read
October 30, 2026
Erik Vaessen on the costs, complexities, and technologies shaping advanced therapy manufacturing.
5 min read
October 29, 2026
AmacaThera Co-Founder and CEO Mike Cooke reflects on the long road from academic discovery to a potential new treatment for post-operative pain
9 min read
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
False
